Unknown

Dataset Information

Introduction to "Immunotherapies for Multiple Myeloma".


ABSTRACT: Multiple myeloma (MM) is the second most common hematological cancer after diffuse large B-cell lymphoma, accounting for about 10% of all blood cancers [...].

SUBMITTER: Offidani M 

PROVIDER: S-EPMC7696150 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature